Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gibbons

Showing results (281-290 of 523) with videos related to

Pageof 53
Sort By:
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.
The Journal of Clinical Investigation|April 26, 2014
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonismYanan Yang, Young-Ho Ahn, Yulong Chen, et al.
Oncoimmunology|December 22, 2016
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppressionLimo Chen, Xiaohui Yi, Sangeeta Goswami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.
Nature Communications|May 14, 2024
Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissueLucia Montorsi, Michael J Pitcher, Yuan Zhao, et al.
Clinical Lung Cancer|August 9, 2020
Female Gender Predicts Augmented Immune Infiltration in Lung AdenocarcinomaCarmen Behrens, Pedro Rocha, Edwin R Parra, et al.
Nature Communications|September 10, 2020
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8<sup>+</sup> T cell exhaustionDavid H Peng, Bertha Leticia Rodriguez, Lixia Diao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
The Journal of Clinical Investigation|November 22, 2016
Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11Xiaochao Tan, Priyam Banerjee, Hou-Fu Guo, et al.
Pageof 53

Showing results (281-290 of 523) with videos related to

Sort By:
Pageof 53
JCI Insight|July 26, 2021
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancerAparna Padhye, Jessica M Konen, B Leticia Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.
The Journal of Clinical Investigation|April 26, 2014
ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonismYanan Yang, Young-Ho Ahn, Yulong Chen, et al.
Oncoimmunology|December 22, 2016
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppressionLimo Chen, Xiaohui Yi, Sangeeta Goswami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2015
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal TransitionMilena P Mak, Pan Tong, Lixia Diao, et al.
Nature Communications|May 14, 2024
Double-negative B cells and DNASE1L3 colocalise with microbiota in gut-associated lymphoid tissueLucia Montorsi, Michael J Pitcher, Yuan Zhao, et al.
Clinical Lung Cancer|August 9, 2020
Female Gender Predicts Augmented Immune Infiltration in Lung AdenocarcinomaCarmen Behrens, Pedro Rocha, Edwin R Parra, et al.
Nature Communications|September 10, 2020
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8<sup>+</sup> T cell exhaustionDavid H Peng, Bertha Leticia Rodriguez, Lixia Diao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2021
Poziotinib for Patients With <i>HER2</i> Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II TrialYasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter, et al.
The Journal of Clinical Investigation|November 22, 2016
Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11Xiaochao Tan, Priyam Banerjee, Hou-Fu Guo, et al.
Pageof 53